Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C A Peabody

Showing results (1-10 of 49) with videos related to

Pageof 5
Sort By:
The Journal of Clinical Psychiatry|September 1, 1987
Trazodone withdrawal and formicationC A Peabody
Psychiatric Services (Washington, D.C.)|December 1, 1995
Reliability of diagnoses made by psychiatric residents in a general emergency departmentM D Warner, C A Peabody
The American Journal of Psychiatry|April 1, 1985
Olfactory deficits and primary degenerative dementiaC A Peabody, J R Tinklenberg
The Australian and New Zealand Journal of Psychiatry|December 1, 1989
The differential diagnosis of negative symptoms in chronic schizophreniaH A Whiteford, C A Peabody
The Journal of Clinical Psychiatry|February 1, 1993
High initial nortriptyline doses in the treatment of depressionM D Warner, M Griffin, C A Peabody
Biological Psychiatry|January 1, 1987
Tardive dyskinesia after low-dose haloperidolC A Peabody, D Brody, M D Warner
Clinical Pharmacokinetics|September 1, 1995
Clinical relevance of drug interactions with lithiumP R Finley, M D Warner, C A Peabody
The American Journal of Psychiatry|February 1, 1986
Thyrotropin-releasing hormone (TRH) and Alzheimer's diseaseC A Peabody, T E Deblois, J R Tinklenberg
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|August 1, 1993
Growth hormone and prolactin variants in normal subjects. Relative proportions in morning and afternoon samplesM D Warner, Y N Sinha, C A Peabody
Biological Psychiatry|October 1, 1993
Potential abnormalities in molecular forms of growth hormone in schizophrenia: a pilot studyM D Warner, Y N Sinha, C A Peabody
Pageof 5

Showing results (1-10 of 49) with videos related to

Sort By:
Pageof 5
The Journal of Clinical Psychiatry|September 1, 1987
Trazodone withdrawal and formicationC A Peabody
Psychiatric Services (Washington, D.C.)|December 1, 1995
Reliability of diagnoses made by psychiatric residents in a general emergency departmentM D Warner, C A Peabody
The American Journal of Psychiatry|April 1, 1985
Olfactory deficits and primary degenerative dementiaC A Peabody, J R Tinklenberg
The Australian and New Zealand Journal of Psychiatry|December 1, 1989
The differential diagnosis of negative symptoms in chronic schizophreniaH A Whiteford, C A Peabody
The Journal of Clinical Psychiatry|February 1, 1993
High initial nortriptyline doses in the treatment of depressionM D Warner, M Griffin, C A Peabody
Biological Psychiatry|January 1, 1987
Tardive dyskinesia after low-dose haloperidolC A Peabody, D Brody, M D Warner
Clinical Pharmacokinetics|September 1, 1995
Clinical relevance of drug interactions with lithiumP R Finley, M D Warner, C A Peabody
The American Journal of Psychiatry|February 1, 1986
Thyrotropin-releasing hormone (TRH) and Alzheimer's diseaseC A Peabody, T E Deblois, J R Tinklenberg
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|August 1, 1993
Growth hormone and prolactin variants in normal subjects. Relative proportions in morning and afternoon samplesM D Warner, Y N Sinha, C A Peabody
Biological Psychiatry|October 1, 1993
Potential abnormalities in molecular forms of growth hormone in schizophrenia: a pilot studyM D Warner, Y N Sinha, C A Peabody
Pageof 5